T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Fidelity National Information Services
FIS
$22.8B
| $60.3M | 0.01% |
812,874
+11,655
| +1% | +$759K |
|
677
Immunovant
IMVT
$8.64B
| $60.2M | 0.01% |
1,862,043
+259,481
| +16% | +$9.47M |
|
678
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
| $59.7M | 0.01% |
385,338
+17,553
| +5% | +$2.43M |
|
679
Digital Realty Trust
DLR
$73.1B
| $59.6M | 0.01% |
413,917
-307,275
| -43% | -$43.4M |
|
680
Oscar Health
OSCR
$9.5B
| $59.2M | 0.01% |
3,978,152
+2,409,160
| +154% | +$33M |
|
681
Option Care Health
OPCH
$3.61B
| $59M | 0.01% |
1,760,482
+23,676
| +1% | +$766K |
|
|
XYZ
682
Block Inc
XYZ
$49.9B
| $59M | 0.01% |
697,523
-142,101
| -17% | -$10.3M |
|
683
Pliant Therapeutics
PLRX
$66.9M
| $59M | 0.01% |
3,959,088
+173,172
| +5% | +$2.86M |
|
684
Agios Pharmaceuticals
AGIO
$2B
| $58.9M | 0.01% |
2,012,993
+388,381
| +24% | +$10.4M |
|
685
Disc Medicine
IRON
$3.07B
| $58.8M | 0.01% |
944,213
+353,382
| +60% | +$22.9M |
|
686
Occidental Petroleum
OXY
$57.7B
| $58.8M | 0.01% |
904,081
+8,863
| +1% | +$529K |
|
687
Blue Owl Capital
OWL
$19.7B
| $58.5M | 0.01% |
3,101,594
-3,981
| -0.1% | -$66.7K |
|
688
Prudential Financial
PRU
$43B
| $58.5M | 0.01% |
498,247
+2,001
| +0.4% | +$216K |
|
689
FTAI Aviation
FTAI
$22.2B
| $58.4M | 0.01% |
867,963
+813,311
| +1,488% | +$44.6M |
|
|
NEE.PRR
690
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| – | – |
0
| – | – |
|
691
Live Nation Entertainment
LYV
$43.3B
| $57.8M | 0.01% |
546,372
-111,192
| -17% | -$10.5M |
|
692
Unilever
UL
$135B
| $57.3M | 0.01% |
1,015,003
+190,787
| +23% | +$10.6M |
|
693
Relay Therapeutics
RLAY
$4.37B
| $57.1M | 0.01% |
6,879,597
-1,701,570
| -20% | -$16.6M |
|
694
Abercrombie & Fitch
ANF
$4.84B
| $57M | 0.01% |
454,550
+141,788
| +45% | +$16.2M |
|
695
CorVel
CRVL
$3.25B
| $56.9M | 0.01% |
648,963
-5,502
| -0.8% | -$442K |
|
696
Corteva
CTVA
$50.6B
| $56.7M | 0.01% |
983,916
+4,498
| +0.5% | +$232K |
|
697
Watsco Inc
WSO
$12.9B
| $56.7M | 0.01% |
131,149
+443
| +0.3% | +$178K |
|
698
Estee Lauder
EL
$31.6B
| $56.6M | 0.01% |
367,218
+5,915
| +2% | +$839K |
|
699
Dick's Sporting Goods
DKS
$18.1B
| $56.2M | 0.01% |
249,958
-34,457
| -12% | -$5.89M |
|
700
Synchrony
SYF
$26.1B
| $56.1M | 0.01% |
1,300,576
+342,979
| +36% | +$13.7M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.